Regulation of ferrochelatase gene expression by hypoxia

YL Liu, SO Ang, DA Weigent, JT Prchal, JR Bloomer - Life sciences, 2004 - Elsevier
YL Liu, SO Ang, DA Weigent, JT Prchal, JR Bloomer
Life sciences, 2004Elsevier
Ferrochelatase (FECH), the last enzyme of the heme biosynthetic pathway, catalyzes the
insertion of iron into protoporphyrin to form heme. This pathway provides heme for
hemoglobin and other essential hemoproteins. The regulatory role of oxygen in the pathway
has not been clearly established. In this study, we examined whether FECH gene
expression is upregulated during hypoxia by a mechanism which involves the hypoxia-
inducible factor 1 (HIF-1). Two HIF-1 binding motifs were identified within the− 150 bp FECH …
Ferrochelatase (FECH), the last enzyme of the heme biosynthetic pathway, catalyzes the insertion of iron into protoporphyrin to form heme. This pathway provides heme for hemoglobin and other essential hemoproteins. The regulatory role of oxygen in the pathway has not been clearly established. In this study, we examined whether FECH gene expression is upregulated during hypoxia by a mechanism which involves the hypoxia-inducible factor 1 (HIF-1). Two HIF-1 binding motifs were identified within the −150 bp FECH minimal promoter sequence. Exposure of HEL, K562, and Hep-G2 cells to hypoxia for 18 hours resulted in a significant increase in FECH mRNA expression (p < 0.05). Hypoxia also transactivated the minimal promoter for the FECH gene in the cells. Transient co-expression of wild-type HIF-1α or a dominant negative HIF-1α with the FECH minimal promoter luciferase construct stimulated or blocked FECH promoter activity, respectively. Expression of the von Hippel-Lindau (VHL) tumor suppressor factor blocked the expression of both FECH mRNA and HIF-1α protein during normoxic culture of renal carcinoma cell line (RCC4). The results suggest that the FECH gene is a target for HIF-1 during hypoxia.
Elsevier